HyperCVAD is an intensive, “pediatric-inspired” chemotherapy regimen that serves as a standard treatment backbone for adult Acute Lymphoblastic Leukemia (ALL).
The regimen is characterized by its sequential, alternating cycle structure, typically totaling 8 cycles followed by a long-term maintenance phase.
Regimen Components
The name is an acronym for the drugs used in “Arm A,” which alternates with “Arm B”:
- Arm A (Cycles 1, 3, 5, 7): Includes hyperfractionated cyclophosphamide, vincristine, Adriamycin (doxorubicin), and dexamethasone.
- Arm B (Cycles 2, 4, 6, 8): Consists of high-dose methotrexate and high-dose cytarabine (Ara-C).
Clinical Applications and Modifications
- Ph-Positive ALL: In patients with the Philadelphia chromosome, HyperCVAD is combined with a Tyrosine Kinase Inhibitor (TKI) such as ponatinib, dasatinib, or imatinib.
- Sanctuary Site Protection: Mandatory intrathecal chemotherapy (methotrexate and cytarabine) is built into the protocol to prevent relapse in the Central Nervous System.
- Age-Based Dosing: For patients over 60, the dose of cytarabine is typically reduced to 1,000 mg/m² to minimize neurotoxicity and improve tolerance.
- Supportive Care: Arm B requires leucovorin rescue beginning 24 hours after the methotrexate infusion to prevent severe systemic toxicity.
Key Toxicities
- Myelosuppression: profound neutropenia, thrombocytopenia, anemia
- Neurotoxicity: vincristine-related peripheral neuropathy
- Cardiotoxicity: doxorubicin cumulative dose risk
- Mucositis and gastrointestinal toxicity
- Renal toxicity: methotrexate requires hydration and leucovorin rescue
- Tumor lysis syndrome (TLS) risk (especially with high tumor burden)
- Infections – high risk due to prolonged neutropenia
Monitoring
- CBC with differential (frequent)
- Renal and liver function tests
- Cardiac function (ejection fraction baseline and during therapy)
- Neurologic assessment (vincristine toxicity)
- Methotrexate serum levels to guide leucovorin rescue
- Electrolytes and TLS labs during therapy
Supportive Care
- Leucovorin rescue post-methotrexate
- Aggressive hydration to prevent renal toxicity
- Antimicrobial prophylaxis (bacterial, fungal, PCP)
- Growth factor support (G-CSF) may be used
Other Notes
- CNS prophylaxis via high-dose methotrexate and cytarabine courses
- Often combined with intrathecal chemotherapy
- Requires experienced oncology team and close monitoring due to toxicity
Synonyms
Hyper-CVAD, HyperCVAD